Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2019 Results Earnings Conference Call May 1, 2019 8:00 AM ET Company Participants Kimberly Lee - Head, Investor Relations and Corporate Strategy Lonnel Coats - President and Chief Executive Officer Pablo Lapuerta - Executive Vice President and Chief Medical Officer Jeffrey Wade - Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer Praveen Tyle - Executive Vice President, Research and Development Conference Call Participant ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification Number) 8800 Technology Forest Place The Woodla ...

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2018 Earnings Conference Call March 13, 2019 8:00 AM ET Company Participants Kimberly Lee - Head, Investor Relations and Corporate Strategy Lonnel Coats - President, CEO & Director Alexander Santini - EVP & Chief Commercial Officer Pablo Lapuerta - EVP & Chief Medical Officer Jeffrey Wade - EVP, Corporate & Administrative Affairs and CFO Praveen Tyle - EVP, Research & Development Conference Call Participants Liana Moussatos - Wedbush Securities Samantha Semenko ...